Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Depreciation & Amortization (CF) (2016 - 2025)

iBio (IBIO) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $141000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 15.57% to $141000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $506000.0, a 8.17% decrease, with the full-year FY2025 number at $484000.0, down 24.14% from a year prior.
  • Depreciation & Amortization (CF) was $141000.0 for Q4 2025 at iBio, up from $123000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $743000.0 in Q2 2022 to a low of $117000.0 in Q4 2022.
  • A 5-year average of $229800.0 and a median of $144000.0 in 2021 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): soared 495.8% in 2022, then plummeted 83.07% in 2023.
  • iBio's Depreciation & Amortization (CF) stood at $517000.0 in 2021, then crashed by 77.37% to $117000.0 in 2022, then surged by 40.17% to $164000.0 in 2023, then fell by 25.61% to $122000.0 in 2024, then rose by 15.57% to $141000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Depreciation & Amortization (CF) are $141000.0 (Q4 2025), $123000.0 (Q3 2025), and $121000.0 (Q2 2025).